Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC

por Panoskaltsis, T., Papadimitriou, C., Pallas, N., Karamveri, C., Kyziridis, D., Hristakis, C., Kiriakopoulos, V., Kalakonas, A., Vaikos, D., Tzavara, C., Tentes, A. A.
Publicado 2023

Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

por Bafaloukos, D, Papadimitriou, C, Linardou, H, Aravantinos, G, Papakostas, P, Skarlos, D, Kosmidis, P, Fountzilas, G, Gogas, H, Kalofonos, C, Dimopoulos, A M
Publicado 2004

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

por Zagouri, F, Bago-Horvath, Z, Rössler, F, Brandstetter, A, Bartsch, R, Papadimitriou, C A, Dimitrakakis, C, Tsigginou, A, Papaspyrou, I, Giannos, A, Dimopoulos, M-A, Filipits, M
Publicado 2013

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer

por Carlsson, G., Koumarianou, A., Guren, T.K., Haux, J., Katsaounis, P., Kentepozidis, N., Pfeiffer, P., Brændengen, M., Mavroudis, D., Taflin, H., Skintemo, L., Tell, R., Papadimitriou, C.
Publicado 2022

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

por Ihnen, M, Wirtz, R M, Kalogeras, K T, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, A G, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G, Müller, V
Publicado 2010